FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013173881> ?p ?o ?g. }

• W2013173881 endingPage "1222" @default.
• W2013173881 startingPage "1215" @default.
• W2013173881 abstract "Hyponatremia is the most common electrolyte disorder in clinical practice. Its incidence increases with age and it is associated with increased morbidity and mortality. Recently, the vaptans, antagonists of the arginine vasopressin pathway, have shown promise for safe treatment of hyponatremia. Here we evaluated the efficacy, safety, and tolerability of oral lixivaptan, a selective vasopressin V2-receptor antagonist, for treatment of nonhospitalized individuals with euvolemic hyponatremia (sodium less than 135 mmol/l) in a multicenter, randomized, double-blind, placebo-controlled, phase III study. About half of the 206 patients were elderly in a chronic care setting. Of these patients, 52 were given a placebo and 154 were given 25-100 mg per day lixivaptan, titrated based on the daily serum sodium measurements. Compared with placebo (0.8 mmol/l), the serum sodium concentration significantly increased by 3.2 mmol/l from baseline to day 7 (primary efficacy endpoint) with lixivaptan treatment. A significantly greater proportion of patients that received lixivaptan achieved normal serum sodium (39.4%) by day 7 relative to placebo (12.2%). Overall, lixivaptan was considered safe and well-tolerated. Thus, oral lixivaptan can be safely initiated in the outpatient setting and effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia." @default.
• W2013173881 created "2016-06-24" @default.
• W2013173881 creator A5003930182 @default.
• W2013173881 creator A5008684187 @default.
• W2013173881 creator A5009838266 @default.
• W2013173881 creator A5015986391 @default.
• W2013173881 creator A5032995631 @default.
• W2013173881 creator A5054084408 @default.
• W2013173881 creator A5066236336 @default.
• W2013173881 creator A5066384461 @default.
• W2013173881 creator A5073134238 @default.
• W2013173881 date "2012-12-01" @default.
• W2013173881 modified "2023-10-16" @default.
• W2013173881 title "Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia" @default.
• W2013173881 cites W132299086 @default.
• W2013173881 cites W1974987609 @default.
• W2013173881 cites W1975355688 @default.
• W2013173881 cites W1988993398 @default.
• W2013173881 cites W2003695859 @default.
• W2013173881 cites W2012866260 @default.
• W2013173881 cites W2022217182 @default.
• W2013173881 cites W2023270528 @default.
• W2013173881 cites W2024143898 @default.
• W2013173881 cites W2040609083 @default.
• W2013173881 cites W2053886170 @default.
• W2013173881 cites W2065336867 @default.
• W2013173881 cites W2065944391 @default.
• W2013173881 cites W2090069728 @default.
• W2013173881 cites W2097908284 @default.
• W2013173881 cites W2101149840 @default.
• W2013173881 cites W2111111770 @default.
• W2013173881 cites W2120040647 @default.
• W2013173881 cites W2135149679 @default.
• W2013173881 cites W2145281681 @default.
• W2013173881 cites W2148024427 @default.
• W2013173881 cites W2163928404 @default.
• W2013173881 doi "https://doi.org/10.1038/ki.2012.274" @default.
• W2013173881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22932122" @default.
• W2013173881 hasPublicationYear "2012" @default.
• W2013173881 type Work @default.
• W2013173881 sameAs 2013173881 @default.
• W2013173881 citedByCount "38" @default.
• W2013173881 countsByYear W20131738812012 @default.
• W2013173881 countsByYear W20131738812013 @default.
• W2013173881 countsByYear W20131738812014 @default.
• W2013173881 countsByYear W20131738812015 @default.
• W2013173881 countsByYear W20131738812016 @default.
• W2013173881 countsByYear W20131738812017 @default.
• W2013173881 countsByYear W20131738812018 @default.
• W2013173881 countsByYear W20131738812019 @default.
• W2013173881 countsByYear W20131738812020 @default.
• W2013173881 countsByYear W20131738812022 @default.
• W2013173881 crossrefType "journal-article" @default.
• W2013173881 hasAuthorship W2013173881A5003930182 @default.
• W2013173881 hasAuthorship W2013173881A5008684187 @default.
• W2013173881 hasAuthorship W2013173881A5009838266 @default.
• W2013173881 hasAuthorship W2013173881A5015986391 @default.
• W2013173881 hasAuthorship W2013173881A5032995631 @default.
• W2013173881 hasAuthorship W2013173881A5054084408 @default.
• W2013173881 hasAuthorship W2013173881A5066236336 @default.
• W2013173881 hasAuthorship W2013173881A5066384461 @default.
• W2013173881 hasAuthorship W2013173881A5073134238 @default.
• W2013173881 hasBestOaLocation W20131738811 @default.
• W2013173881 hasConcept C126322002 @default.
• W2013173881 hasConcept C142724271 @default.
• W2013173881 hasConcept C168563851 @default.
• W2013173881 hasConcept C178790620 @default.
• W2013173881 hasConcept C185592680 @default.
• W2013173881 hasConcept C197934379 @default.
• W2013173881 hasConcept C203092338 @default.
• W2013173881 hasConcept C204787440 @default.
• W2013173881 hasConcept C27081682 @default.
• W2013173881 hasConcept C2776370428 @default.
• W2013173881 hasConcept C2776703092 @default.
• W2013173881 hasConcept C2778375690 @default.
• W2013173881 hasConcept C2780615674 @default.
• W2013173881 hasConcept C537181965 @default.
• W2013173881 hasConcept C71924100 @default.
• W2013173881 hasConcept C90924648 @default.
• W2013173881 hasConceptScore W2013173881C126322002 @default.
• W2013173881 hasConceptScore W2013173881C142724271 @default.
• W2013173881 hasConceptScore W2013173881C168563851 @default.
• W2013173881 hasConceptScore W2013173881C178790620 @default.
• W2013173881 hasConceptScore W2013173881C185592680 @default.
• W2013173881 hasConceptScore W2013173881C197934379 @default.
• W2013173881 hasConceptScore W2013173881C203092338 @default.
• W2013173881 hasConceptScore W2013173881C204787440 @default.
• W2013173881 hasConceptScore W2013173881C27081682 @default.
• W2013173881 hasConceptScore W2013173881C2776370428 @default.
• W2013173881 hasConceptScore W2013173881C2776703092 @default.
• W2013173881 hasConceptScore W2013173881C2778375690 @default.
• W2013173881 hasConceptScore W2013173881C2780615674 @default.
• W2013173881 hasConceptScore W2013173881C537181965 @default.
• W2013173881 hasConceptScore W2013173881C71924100 @default.
• W2013173881 hasConceptScore W2013173881C90924648 @default.
• W2013173881 hasIssue "11" @default.
• W2013173881 hasLocation W20131738811 @default.
• W2013173881 hasLocation W20131738812 @default.

• next